Skip to main content

Table 4 Nomogram estimates for risk of LRS at pre-radiotherapy and at time of data analysis

From: A prospective study of nomogram-based adaptation of prostate radiotherapy target volumes

 

Pre-RT

At analysis

Paired t-test

ECE

70.7 % (20.8)

87.1 % (13.8)

p < 0.001

SVI

47.0 % (24.1)

43.5 % (24.7)

p = 0.356

LNI

32.05 % (27.7)

50.4 % (26.9)

p < 0.001

  1. Data is presented as mean (standard deviation)
  2. Two patients with known pelvic lymph node metastases were entered as 100 % risk of LNI